Scopia Capital Management LP United Therapeutics Corp Transaction History

Scopia Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $48.5 Million - $57.9 Million	-269,455 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $10.3 Million - $12.8 Million	60,170 Added 28.75%	269,455 $48.3 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $578,660 - $657,261	3,759 Added 1.83%	209,285 $35 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $20.9 Million - $31.2 Million	205,526 New	205,526 $31.2 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Scopia Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Scopia Capital Management LP with notifications on news.